세계의 경피적풍선척추성형술 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2032년)

The global demand for Kyphoplasty Market is presumed to reach the market size of nearly USD 1153.4 Million by 2032 from USD 694.99 Million in 2023 with a CAGR of 5.79% under the study period 2024-2032.

Kyphoplasty is a minimally invasive surgical procedure used to treat spinal fractures, especially those caused by osteoporosis. It involves inserting a balloon into the fractured vertebra and inflating it to create space. A special cement is then injected into the cavity to stabilize the vertebra and reduce pain. Kyphoplasty helps restore vertebral height, prevent further spinal deformity, and provide immediate pain relief, improving patient mobility and quality of life. It is a common treatment for vertebral compression fractures.

Market Dynamics

The increasing prevalence of osteoporosis and vertebral fractures, especially among the elderly population, is a significant factor driving the Kyphoplasty market. Kyphoplasty provides a minimally invasive solution to treat spinal fractures, which has gained popularity due to its effectiveness in pain relief and restoring mobility. The aging global population and rising awareness about the benefits of kyphoplasty are further contributing to the market's growth. Additionally, advancements in medical technology, such as image-guided systems and innovative balloon catheter designs, are making kyphoplasty procedures safer and more accessible, thus boosting the market demand. However, high procedural costs and limited patient awareness may challenge the Kyphoplasty market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Kyphoplasty. The growth and trends of Kyphoplasty industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Kyphoplasty market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product

• Balloon Catheters
• Bone Access Devices
• Cement Application Products
• Bone Cement
• Cement Mixing Systems
• Instruments

By Application

• Vertebral Alignment Restoration
• Spinal Fractures
• Kyphosis

By Indication

• Osteoporosis
• Others

By End-Use

• Hospitals & Clinics
• Ambulatory Surgical Centers

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Kyphoplasty market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Kyphoplasty market include Stryker, Medtronic Inc., Smith & Nephew, MicroPort Scientific Corporation, DePuy Synthes (Johnson & Johnson Services Inc.), CareFusion, G21 S.R.L., Merit Medical Systems, Joimax GmbH, Joline GmbH & Co. KG, Seawon MediTech, Hensler Surgical Products, Taeyeon Medical Co. Ltd., IMEDICOM, Merit Medical Systems, Jiangsu ChangMei Medtech Co. Ltd, IZI Medical Products. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. KYPHOPLASTY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Indication
  • 3.7.4 Market Attractiveness Analysis By End-Use
  • 3.7.5 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL KYPHOPLASTY MARKET ANALYSIS BY PRODUCT

• 5.1. Overview By Product
• 5.2. Historical and Forecast Data
• 5.3. Analysis By Product
• 5.4. Balloon Catheters Historic and Forecast Sales By Regions
• 5.5. Bone Access Devices Historic and Forecast Sales By Regions
• 5.6. Cement Application Products Historic and Forecast Sales By Regions
• 5.7. Bone Cement Historic and Forecast Sales By Regions
• 5.8. Cement Mixing Systems Historic and Forecast Sales By Regions
• 5.9. Instruments Historic and Forecast Sales By Regions

6. GLOBAL KYPHOPLASTY MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data
• 6.3. Analysis By Application
• 6.4. Vertebral Alignment Restoration Historic and Forecast Sales By Regions
• 6.5. Spinal Fractures Historic and Forecast Sales By Regions
• 6.6. Kyphosis Historic and Forecast Sales By Regions

7. GLOBAL KYPHOPLASTY MARKET ANALYSIS BY INDICATION

• 7.1. Overview By Indication
• 7.2. Historical and Forecast Data
• 7.3. Analysis By Indication
• 7.4. Osteoporosis Historic and Forecast Sales By Regions
• 7.5. Others Historic and Forecast Sales By Regions

8. GLOBAL KYPHOPLASTY MARKET ANALYSIS BY END-USE

• 8.1. Overview By End-Use
• 8.2. Historical and Forecast Data
• 8.3. Analysis By End-Use
• 8.4. Hospitals & Clinics Historic and Forecast Sales By Regions
• 8.5. Ambulatory Surgical Centers Historic and Forecast Sales By Regions

9. GLOBAL KYPHOPLASTY MARKET ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook
• 9.2. Introduction
• 9.3. North America Sales Analysis
  • 9.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.3.2 North America By Segment Sales Analysis
  • 9.3.3 North America By Country Sales Analysis
  • 9.3.4 United States Sales Analysis
  • 9.3.5 Canada Sales Analysis
  • 9.3.6 Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.4.2 Europe By Segment Sales Analysis
  • 9.4.3 Europe By Country Sales Analysis
  • 9.4.4 United Kingdom Sales Analysis
  • 9.4.5 France Sales Analysis
  • 9.4.6 Germany Sales Analysis
  • 9.4.7 Italy Sales Analysis
  • 9.4.8 Russia Sales Analysis
  • 9.4.9 Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.5.2 Asia Pacific By Segment Sales Analysis
  • 9.5.3 Asia Pacific By Country Sales Analysis
  • 9.5.4 China Sales Analysis
  • 9.5.5 India Sales Analysis
  • 9.5.6 Japan Sales Analysis
  • 9.5.7 South Korea Sales Analysis
  • 9.5.8 Australia Sales Analysis
  • 9.5.9 South East Asia Sales Analysis
  • 9.5.10 Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.6.2 Latin America By Segment Sales Analysis
  • 9.6.3 Latin America By Country Sales Analysis
  • 9.6.4 Brazil Sales Analysis
  • 9.6.5 Argentina Sales Analysis
  • 9.6.6 Peru Sales Analysis
  • 9.6.7 Chile Sales Analysis
  • 9.6.8 Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 9.7.2 Middle East & Africa By Segment Sales Analysis
  • 9.7.3 Middle East & Africa By Country Sales Analysis
  • 9.7.4 Saudi Arabia Sales Analysis
  • 9.7.5 UAE Sales Analysis
  • 9.7.6 Israel Sales Analysis
  • 9.7.7 South Africa Sales Analysis
  • 9.7.8 Rest Of Middle East And Africa Sales Analysis

10. COMPETITIVE LANDSCAPE OF THE KYPHOPLASTY COMPANIES

• 10.1. Kyphoplasty Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11. COMPANY PROFILES OF KYPHOPLASTY INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Market Concentration Rate
• 11.3. Stryker
  • 11.3.1 Company Overview
  • 11.3.2 Company Revenue
  • 11.3.3 Products
  • 11.3.4 Recent Developments
• 11.4. Medtronic Inc.
  • 11.4.1 Company Overview
  • 11.4.2 Company Revenue
  • 11.4.3 Products
  • 11.4.4 Recent Developments
• 11.5. Smith & Nephew
  • 11.5.1 Company Overview
  • 11.5.2 Company Revenue
  • 11.5.3 Products
  • 11.5.4 Recent Developments
• 11.6. MicroPort Scientific Corporation
  • 11.6.1 Company Overview
  • 11.6.2 Company Revenue
  • 11.6.3 Products
  • 11.6.4 Recent Developments
• 11.7. DePuy Synthes (Johnson & Johnson Services Inc.)
  • 11.7.1 Company Overview
  • 11.7.2 Company Revenue
  • 11.7.3 Products
  • 11.7.4 Recent Developments
• 11.8. CareFusion
  • 11.8.1 Company Overview
  • 11.8.2 Company Revenue
  • 11.8.3 Products
  • 11.8.4 Recent Developments
• 11.9. G21 S.R.L.
  • 11.9.1 Company Overview
  • 11.9.2 Company Revenue
  • 11.9.3 Products
  • 11.9.4 Recent Developments
• 11.10. Merit Medical Systems
  • 11.10.1 Company Overview
  • 11.10.2 Company Revenue
  • 11.10.3 Products
  • 11.10.4 Recent Developments
• 11.11. Joimax GmbH
  • 11.11.1 Company Overview
  • 11.11.2 Company Revenue
  • 11.11.3 Products
  • 11.11.4 Recent Developments
• 11.12. Joline GmbH & Co. KG
  • 11.12.1 Company Overview
  • 11.12.2 Company Revenue
  • 11.12.3 Products
  • 11.12.4 Recent Developments
• 11.13. Seawon MediTech
  • 11.13.1 Company Overview
  • 11.13.2 Company Revenue
  • 11.13.3 Products
  • 11.13.4 Recent Developments
• 11.14. Hensler Surgical Products
  • 11.14.1 Company Overview
  • 11.14.2 Company Revenue
  • 11.14.3 Products
  • 11.14.4 Recent Developments
• 11.15. Taeyeon Medical Co. Ltd.
  • 11.15.1 Company Overview
  • 11.15.2 Company Revenue
  • 11.15.3 Products
  • 11.15.4 Recent Developments
• 11.16. IMEDICOM
  • 11.16.1 Company Overview
  • 11.16.2 Company Revenue
  • 11.16.3 Products
  • 11.16.4 Recent Developments
• 11.17. Merit Medical Systems
  • 11.17.1 Company Overview
  • 11.17.2 Company Revenue
  • 11.17.3 Products
  • 11.17.4 Recent Developments
• 11.18. Jiangsu ChangMei Medtech Co. Ltd
  • 11.18.1 Company Overview
  • 11.18.2 Company Revenue
  • 11.18.3 Products
  • 11.18.4 Recent Developments
• 11.19. IZI Medical Products
  • 11.19.1 Company Overview
  • 11.19.2 Company Revenue
  • 11.19.3 Products
  • 11.19.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies